Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chava Kimchi-Sarfaty

Showing results (1-10 of 86) with videos related to

Pageof 9
Sort By:
Human Mutation|July 17, 2022
Multiple mechanisms contribute to the phenotypic effects of synonymous variantsUpendra Katneni, Chava Kimchi-Sarfaty
Current Pharmaceutical Biotechnology|November 17, 2004
SV40 pseudovirions as highly efficient vectors for gene transfer and their potential application in cancer therapyChava Kimchi-Sarfaty, Michael M Gottesman
Pharmacogenomics|August 17, 2011
SNPs in ADAMTS13Sandra Chang Tseng, Chava Kimchi-Sarfaty
British Journal of Haematology|November 20, 2023
A synonymous variant is unmasked in thalassaemiaRyan C Hunt, Chava Kimchi-Sarfaty
Nature Reviews. Genetics|September 1, 2011
Understanding the contribution of synonymous mutations to human diseaseZuben E Sauna, Chava Kimchi-Sarfaty
Cold Spring Harbor Protocols|September 6, 2012
SV40 in vitro packaging: a pseudovirion gene delivery systemChava Kimchi-Sarfaty, Michael M Gottesman
The New England Journal of Medicine|August 24, 2022
When Silence DisruptsRyan C Hunt, Chava Kimchi-Sarfaty
Journal of the National Cancer Institute|April 28, 2022
Synonymous Variants: Necessary Nuance in Our Understanding of Cancer Drivers and Treatment OutcomesNayiri M Kaissarian, Douglas Meyer, Chava Kimchi-Sarfaty
Trends in Pharmacological Sciences|October 28, 2022
Implementing computational methods in tandem with synonymous gene recoding for therapeutic developmentBrian C Lin, Nayiri M Kaissarian, Chava Kimchi-Sarfaty
Molecular Pharmacology|June 18, 2002
Functional characterization of coding polymorphisms in the human MDR1 gene using a vaccinia virus expression systemChava Kimchi-Sarfaty, John J Gribar, Michael M Gottesman
Pageof 9

Showing results (1-10 of 86) with videos related to

Sort By:
Pageof 9
Human Mutation|July 17, 2022
Multiple mechanisms contribute to the phenotypic effects of synonymous variantsUpendra Katneni, Chava Kimchi-Sarfaty
Current Pharmaceutical Biotechnology|November 17, 2004
SV40 pseudovirions as highly efficient vectors for gene transfer and their potential application in cancer therapyChava Kimchi-Sarfaty, Michael M Gottesman
Pharmacogenomics|August 17, 2011
SNPs in ADAMTS13Sandra Chang Tseng, Chava Kimchi-Sarfaty
British Journal of Haematology|November 20, 2023
A synonymous variant is unmasked in thalassaemiaRyan C Hunt, Chava Kimchi-Sarfaty
Nature Reviews. Genetics|September 1, 2011
Understanding the contribution of synonymous mutations to human diseaseZuben E Sauna, Chava Kimchi-Sarfaty
Cold Spring Harbor Protocols|September 6, 2012
SV40 in vitro packaging: a pseudovirion gene delivery systemChava Kimchi-Sarfaty, Michael M Gottesman
The New England Journal of Medicine|August 24, 2022
When Silence DisruptsRyan C Hunt, Chava Kimchi-Sarfaty
Journal of the National Cancer Institute|April 28, 2022
Synonymous Variants: Necessary Nuance in Our Understanding of Cancer Drivers and Treatment OutcomesNayiri M Kaissarian, Douglas Meyer, Chava Kimchi-Sarfaty
Trends in Pharmacological Sciences|October 28, 2022
Implementing computational methods in tandem with synonymous gene recoding for therapeutic developmentBrian C Lin, Nayiri M Kaissarian, Chava Kimchi-Sarfaty
Molecular Pharmacology|June 18, 2002
Functional characterization of coding polymorphisms in the human MDR1 gene using a vaccinia virus expression systemChava Kimchi-Sarfaty, John J Gribar, Michael M Gottesman
Pageof 9